West Pharmaceutical Stock - Long-term drivers and business model in focus
Published on 06/20/2026 at 15:48 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 15:47 CET. Details in the imprint.
West Pharmaceutical (US9523901012) develops and manufactures components and systems for injectable drug delivery worldwide. With no fresh market-moving news confirmed from primary sources today, this Saturday’s piece centers on the company’s long-term earnings drivers and business model.
All news and key data on West Pharmaceutical stock
Track recent company announcements, historical articles and price data on West Pharmaceutical stock in one place.
How West Pharmaceutical earns its money
West Pharmaceutical Services Inc. reports two main operating segments: Proprietary Products and Contract-Manufactured Products, with the former generating the bulk of revenue and profit.
The Proprietary Products segment includes high-value components such as elastomer stoppers and seals for injectable drugs, as well as prefilled syringe and cartridge components used by global pharmaceutical and biotech companies.
Long-term revenue and margin drivers
According to company disclosures, West Pharmaceutical’s long-term growth is closely tied to injectable biologics, vaccines and specialty medicines, where high-barrier packaging and delivery components are critical to product safety and regulatory compliance.
The company also benefits from a largely recurring revenue profile, because components must be ordered for each vial, syringe or cartridge filled, which links volumes directly to customers’ ongoing drug demand.
The product behind the stock
At the core of West Pharmaceutical’s portfolio are coated elastomer stoppers and seals used in injectable drug vials, prefilled syringes and cartridges, aimed at protecting sensitive biologic medicines during storage and administration.
Where the stock trades today
West Pharmaceutical shares (US9523901012) trade on the New York Stock Exchange at $327.95 as of 06/18/2026, 16:00 ET.
Key facts on West Pharmaceutical stock
- Company: West Pharmaceutical Services Inc.
- ISIN: US9523901012
- WKN: 851962
- Ticker: WST
- Venue: NYSE
- Price (as of 06/18/2026, 16:00 ET): 327.95 USD
- Market cap: 23.17 billion USD (as of 06/18/2026)
- Sector / Industry: Health Care / Medical supplies and packaging
- Index membership: Standard & Poor's 500 index
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
